{"id":753031,"date":"2023-05-01T09:02:01","date_gmt":"2023-05-01T13:02:01","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/"},"modified":"2023-05-01T09:02:01","modified_gmt":"2023-05-01T13:02:01","slug":"zymeworks-announces-participation-in-upcoming-investor-conferences-9","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/","title":{"rendered":"Zymeworks Announces Participation in Upcoming Investor Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">VANCOUVER, British Columbia, May  01, 2023  (GLOBE NEWSWIRE) &#8212; Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences:<\/p>\n<ul type=\"disc\">\n<li>Bank of America Global Healthcare Conference. Zymeworks\u2019 management will participate in one-on-one meetings and present on May 11 at 8:55 am Pacific Time in Las Vegas, NV.<\/li>\n<li>Jefferies Global Healthcare Conference: Zymeworks\u2019 management will participate in one-on-one meetings and present on June 7-9 in New York, NY.<\/li>\n<\/ul>\n<p>All presentations and webcasts will be available on Zymeworks\u2019 website at <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=np6U6eGSK0cm4j1rG2zkNSrZyBlMPKOf8vLqf7gTUT-Y_EI3Rso67G15kTMpfGT3g1ltvuI3ElGlK7vIP1aqUov5uUbyDCmgRRv7B-I6BcVChy9aZxvqjmKHji2qR1hcUIAcog8CQOSkmksesfcTdnN_TfD30kLsGCsykSsK0ng=\" rel=\"nofollow noopener\" target=\"_blank\">http:\/\/ir.zymeworks.com\/events-and-presentations<\/a>.<\/p>\n<p>\n        <strong>About Zymeworks Inc. <\/strong>\n      <\/p>\n<p>Zymeworks Inc. (Nasdaq: ZYME) is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks&#8217; mission is to make a meaningful difference for people impacted by difficult-to-treat cancers and other serious diseases. Zymeworks&#8217; complementary therapeutic platforms and fully integrated drug development engine provide the flexibility and compatibility to precisely engineer and develop highly differentiated antibody-based therapeutic candidates. Zymeworks engineered and developed zanidatamab, a HER2-targeted bispecific antibody using Zymeworks&#8217; proprietary Azymetric\u2122 technology. Zymeworks has entered into separate agreements with BeiGene, Ltd. (BeiGene) and\u00a0Jazz Pharmaceuticals Ireland Limited\u00a0(Jazz), granting each of BeiGene and Jazz with exclusive rights to develop and commercialize zanidatamab in different territories. Zanidatamab is currently being evaluated in global Phase 1, Phase 2, and Phase 3 clinical trials, including certain ongoing pivotal clinical trials as a treatment for patients with HER2-expressing cancers. Zymeworks&#8217; next clinical candidate, zanidatamab zovodotin (ZW49), is a HER2-targeted bispecific antibody-drug conjugate (ADC) developed using Zymeworks&#8217; proprietary Azymetric\u2122 and ZymeLink\u2122 Auristatin technologies. Zanidatamab zovodotin is currently being evaluated in a Phase 1 clinical trial for patients with a variety of HER2-expressing, HER2-amplified or HER2-mutant cancers. Zymeworks is also advancing a deep pipeline of product candidates based on its experience and capabilities in both ADC and multispecific antibodies (MSAT). In addition to Zymeworks&#8217; wholly owned pipeline, its therapeutic platforms have been further leveraged through strategic partnerships with global biopharmaceutical companies. For information about Zymeworks, visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=mxfUNngEOzvaJqaoGNPz4nAQoOygcY8qA5quEU2AjqdPpNdwZToFKtqsTSqrQoYLvApng3JDN8GIL7Zk0JXSVOcbzht717pXu9RiAODR6pZCXGoc_s5_xvS-FjV-MmuNGSRhy2nDeQP73WIdusDrZfMX4Vj9iGwng5lBFLErZtJ_iIBpdvU2QENRIngQe-n_i4t4zyDy-8t01PL67VlUQw==\" rel=\"nofollow noopener\" target=\"_blank\">www.zymeworks.com<\/a>\u00a0and follow\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=LP2dIURIuo43NMY6eXo55pMkwi_fRk-vbj58EfA1TmHi6ugB_5sn4WQegwROoanWntC6QEGRZ9t64ZO9Znmyi1ztdfAq27VdLhWURpCFieb7S2vyhKd9wMUsImbOmvfMBpa3KmBFUzsbXWuQXBMB4sZ-0m7smMRfjGan_tfzseg-w-PqZeIRnsu1eY9FpVnweqi-hzAe9YIGGSHt-Dk_-g==\" rel=\"nofollow noopener\" target=\"_blank\">@ZymeworksInc<\/a>\u00a0on Twitter.<\/p>\n<p>\n        <strong>Contacts:<\/strong>\n      <\/p>\n<p>Investor Inquiries:\u202f\u202f\u00a0\u202f\u00a0<br \/>Jack Spinks\u202f<br \/>Director, Investor Relations<br \/>(604) 678-1388\u202f\u202f\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VF3BsRDVHvZ8vaiiHbTXxrcLsk56vj91Mevuy3r2q9UwCZXPgYWToJdd4uLylRd4kjloa2XfKNrS5RAWLMaXOw==\" rel=\"nofollow noopener\" target=\"_blank\">ir@zymeworks.com<\/a>\u202f\u202f\u00a0<br \/>\u202f\u00a0<br \/>Media Inquiries:\u202f\u202f\u00a0<br \/>Diana Papove<br \/>Director, Corporate Communications<br \/>(604) 678-1388\u202f\u202f\u00a0<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=MgTo0u-Mb26P42ahOtxxi1L5uJWUhWTRh9uR2d3flRYvRZHid7EClHNs9h1_eTDRi3Ds0fT94ujNZO9GuBizYXjc1YN0_Q-8Vue2L9BWnew=\" rel=\"nofollow noopener\" target=\"_blank\">media@zymeworks.com<\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MzdiZjdjZmYtMTQ5ZS00ZGM0LWFhOWMtYWRlMzQ4OTQ3NmY3LTEyNjg0NDI=\/tiny\/Zymeworks-Inc-.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) &#8212; Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences: Bank of America Global Healthcare Conference. Zymeworks\u2019 management will participate in one-on-one meetings and present on May 11 at 8:55 am Pacific Time in Las Vegas, NV. Jefferies Global Healthcare Conference: Zymeworks\u2019 management will participate in one-on-one meetings and present on June 7-9 in New York, NY. All presentations and webcasts will be available on Zymeworks\u2019 website at http:\/\/ir.zymeworks.com\/events-and-presentations. About Zymeworks Inc. Zymeworks Inc. (Nasdaq: ZYME) is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks&#8217; mission is to make &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Zymeworks Announces Participation in Upcoming Investor Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-753031","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Zymeworks Announces Participation in Upcoming Investor Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Zymeworks Announces Participation in Upcoming Investor Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) &#8212; Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences: Bank of America Global Healthcare Conference. Zymeworks\u2019 management will participate in one-on-one meetings and present on May 11 at 8:55 am Pacific Time in Las Vegas, NV. Jefferies Global Healthcare Conference: Zymeworks\u2019 management will participate in one-on-one meetings and present on June 7-9 in New York, NY. All presentations and webcasts will be available on Zymeworks\u2019 website at http:\/\/ir.zymeworks.com\/events-and-presentations. About Zymeworks Inc. Zymeworks Inc. (Nasdaq: ZYME) is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks&#8217; mission is to make &hellip; Continue reading &quot;Zymeworks Announces Participation in Upcoming Investor Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2023-05-01T13:02:01+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Zymeworks Announces Participation in Upcoming Investor Conferences\",\"datePublished\":\"2023-05-01T13:02:01+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/\"},\"wordCount\":369,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/\",\"name\":\"Zymeworks Announces Participation in Upcoming Investor Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM=\",\"datePublished\":\"2023-05-01T13:02:01+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Zymeworks Announces Participation in Upcoming Investor Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Zymeworks Announces Participation in Upcoming Investor Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/","og_locale":"en_US","og_type":"article","og_title":"Zymeworks Announces Participation in Upcoming Investor Conferences - Market Newsdesk","og_description":"VANCOUVER, British Columbia, May 01, 2023 (GLOBE NEWSWIRE) &#8212; Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced that management will participate in the following upcoming investor conferences: Bank of America Global Healthcare Conference. Zymeworks\u2019 management will participate in one-on-one meetings and present on May 11 at 8:55 am Pacific Time in Las Vegas, NV. Jefferies Global Healthcare Conference: Zymeworks\u2019 management will participate in one-on-one meetings and present on June 7-9 in New York, NY. All presentations and webcasts will be available on Zymeworks\u2019 website at http:\/\/ir.zymeworks.com\/events-and-presentations. About Zymeworks Inc. Zymeworks Inc. (Nasdaq: ZYME) is a global biotechnology company committed to the discovery, development, and commercialization of novel, multifunctional biotherapeutics. Zymeworks&#8217; mission is to make &hellip; Continue reading \"Zymeworks Announces Participation in Upcoming Investor Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/","og_site_name":"Market Newsdesk","article_published_time":"2023-05-01T13:02:01+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Zymeworks Announces Participation in Upcoming Investor Conferences","datePublished":"2023-05-01T13:02:01+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/"},"wordCount":369,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/","name":"Zymeworks Announces Participation in Upcoming Investor Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM=","datePublished":"2023-05-01T13:02:01+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODgyODgxOCM1NTY2NDM4IzIyNTY4OTM="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/zymeworks-announces-participation-in-upcoming-investor-conferences-9\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Zymeworks Announces Participation in Upcoming Investor Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753031","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=753031"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/753031\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=753031"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=753031"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=753031"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}